Fisher Asset Management
UTHR icon

Fisher Asset Management’s United Therapeutics UTHR Stock Holding History

Fisher Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.3M Sell
33,836
-568
-2% -$320K 0.01% 348
2026
Q1 		$20.4M Buy
34,404
+5,047
+17% +$2.51M 0.01% 329
2025
Q4 		$14.3M Buy
29,357
+5,777
+24% +$2.69M ﹤0.01% 368
2025
Q3 		$9.89M Buy
23,580
+4,987
+27% +$1.68M ﹤0.01% 411
2025
Q2 		$5.34M Buy
18,593
+4
+0% +$1.2K ﹤0.01% 471
2025
Q1 		$5.73M Buy
18,589
+2,250
+14% +$771K ﹤0.01% 475
2024
Q4 		$5.77M Buy
16,339
+10,034
+159% +$3.69M ﹤0.01% 486
2024
Q3 		$2.26M Buy
6,305
+1,150
+22% +$388K ﹤0.01% 567
2024
Q2 		$1.64M Buy
5,155
+334
+7% +$88.4K ﹤0.01% 616
2024
Q1 		$1.11M Buy
4,821
+993
+26% +$224K ﹤0.01% 674
2023
Q4 		$842K Buy
3,828
+209
+6% +$48.2K ﹤0.01% 713
2023
Q3 		$817K Sell
3,619
-730
-17% -$168K ﹤0.01% 780
2023
Q2 		$960K Buy
4,349
+23
+0.5% +$5.09K ﹤0.01% 783
2023
Q1 		$969K Sell
4,326
-93
-2% -$22.9K ﹤0.01% 779
2022
Q4 		$1.23M Buy
+4,419
New +$1.12M ﹤0.01% 735
2018
Q1 		– Sell
-2,649
Closed -$392K – 822
2017
Q4 		$392K Hold
2,649
– – ﹤0.01% 682
2017
Q3 		$310K Sell
2,649
-520
-16% -$66.4K ﹤0.01% 679
2017
Q2 		$411K Buy
3,169
+45
+1% +$5.61K ﹤0.01% 620
2017
Q1 		$423K Hold
3,124
– – ﹤0.01% 579
2016
Q4 		$448K Hold
3,124
– – ﹤0.01% 572
2016
Q3 		$369K Buy
3,124
+32
+1% +$3.85K ﹤0.01% 606
2016
Q2 		$341K Hold
3,092
– – ﹤0.01% 605
2016
Q1 		$357K Sell
3,092
-45
-1% -$5.69K ﹤0.01% 595
2015
Q4 		$491K Buy
3,137
+219
+8% +$31.9K ﹤0.01% 571
2015
Q3 		$383K Buy
2,918
+468
+19% +$75.1K ﹤0.01% 574
2015
Q2 		$426K Hold
2,450
– – ﹤0.01% 468
2015
Q1 		$422K Buy
+2,450
New +$374K ﹤0.01% 461

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Fisher Asset Management's UTHR Position: Q2 2026 in Review

Fisher Asset Management reduced its United Therapeutics (UTHR) stake by 1.7% in Q2 2026, selling an estimated $320K and leaving 33,836 shares worth $18.3M. The position accounts for 0.01% of the portfolio, ranked #348.

Fisher Asset Management first reported a position in UTHR in Q1 2015 and has held it in 27 quarters since. The position peaked at $20.4M in Q1 2026. 878 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Fisher Asset Management held 33,836 shares of United Therapeutics worth $18.3M as of Q2 2026.
  • Fisher Asset Management sold 568 United Therapeutics shares in Q2 2026, an estimated $320K.
  • United Therapeutics made up 0.01% of Fisher Asset Management's portfolio in Q2 2026, its #348 holding.
  • Fisher Asset Management first reported a position in United Therapeutics in Q1 2015 and has held it in 27 quarters since.
  • Fisher Asset Management's United Therapeutics position peaked at $20.4M in Q1 2026.
  • 878 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Fisher Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.